Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon May 20, 2022 3:38pm
169 Views
Post# 34699337

RE:Stock action/Conformal coating

RE:Stock action/Conformal coating Hey Tuna,

Conformal coating shows it works in vivo and in vitro but not sure which islet cells they are using it on. It won't be a while before that goes into humans. The  only update we can realistically expect is some pre-clinical data but I don't think they will share that anytime soon or if they even have to.



TSX listing is next and I doubt it'll help the stock price much but needs to be done. Second catalyst will be an update on patients in the trial in June. After that, i'm guessing a dark period until they get Thyroid into the clinic. They are saying late 2022 but with their track record, I'm not sure I believe that.



If you look at some of the quotes re conformal coating from Evotec, they think gene editing might be the future anyway.








Stockfshr wrote:

Not many stocks showing green again today. But Sernova is one. Been having a tough time breaking through $1.51. Bit of a wall.

The next news release I would like to see is a conformal coating update. I recall someone asking about it on the Sernova/Evotec cc. I can't recall Phillip's answer but it seems to me he avoided getting into any detail. The saved call on Sernova's website does not include the question and answer portion. Anyone recall his response?



<< Previous
Bullboard Posts
Next >>